Author

Ling Yu

Observed names: L. M. Yu, Ling Min Yu, Yu, Ling, Yu, Ling Min

Institutions: Xinyang Normal University, Chengde Medical University

Observed institutions: Xinyang Normal University, Chengde Medical University, Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University

ORCID: 0000-0002-9046-3732

Observed ORCID: 0000-0002-9046-3732

OpenAlex ID: A5101679067

High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients

2018 · L. M. Yu, Y. S. Zhu, et al. · Clinical & Translational Oncology · 20

Recent advances in structural types and medicinal chemistry of PARP-1 inhibitors

2022 · Ling Yu, Zhi-wei Yan, et al. · Medicinal Chemistry Research · 17

Discovery of novel 2,3,4,5-tetrahydrospiro[benzo[c]azepine-1,1’-cyclohexan]-5-ol derivatives as PARP-1 inhibitors

2023 · Ling Yu, Jian-hui Li, et al. · BMC Chemistry · 6

Performance of endoscopic ultrasound for diagnosis of agenesis of the dorsal pancreas: a case report

2019 · Jin Wei Zhong, Ling Min Yu, et al. · Journal of International Medical Research · 5

Dynamic analysis of a Filippov blood glucose insulin model

2024 · Qiongru Wu, Ling Yu, et al. · AIMS Mathematics · 2

Optimal selection of injection doses and injection timings for insulin therapy in a limited time

2020 · Shouzong Liu, Ling Yu, et al. · Advances in Difference Equations · 2

Design and Synthesis of Benzo-Spirocyclic Derivatives as Potent PARP-1 Inhibitors

2024 · Shu Jia, Ling Yu, et al. · Russian Journal of Bioorganic Chemistry

Works count: 11

Citation count: 52

H-index: 4

I10-index: 2